Literature DB >> 1721735

Genetically modified cells: applications for intracerebral grafting.

F H Gage1, M D Kawaja, L J Fisher.   

Abstract

Grafting cells to the CNS is a useful approach to address fundamental and clinical issues in neurobiology. Recently, a hybrid technique - the genetic modification of cells followed by intracerebral implantation - has emerged, which may potentially enhance the power of CNS grafting. However, several methodological considerations need to be addressed to test the reliability of this new approach. Progress in the gene transfer-grafting technique has implications for expanding the range of issues and problems that may be addressed in both the basic science and clinical arenas.

Mesh:

Substances:

Year:  1991        PMID: 1721735     DOI: 10.1016/0166-2236(91)90156-o

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  13 in total

1.  Use of genetically modified glial cells overexpressing laminin alpha1-chain peptides in neurite outgrowth studies.

Authors:  G Webersinke; H C Bauer; C Danninger; I A Krizbai; J C Schittny; J Thalhamer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

2.  Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.

Authors:  Mei Sun; Guo-Rong Zhang; Lingxin Kong; Courtney Holmes; Xiaodan Wang; Wei Zhang; David S Goldstein; Alfred I Geller
Journal:  Hum Gene Ther       Date:  2003-03-20       Impact factor: 5.695

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 4.  Physiological relevance and functional potential of central nervous system-derived cell lines.

Authors:  S R Whittemore; E Y Snyder
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

5.  Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice.

Authors:  L A Terry; E J Usherwood; S Lees; N MacIntyre; A A Nash
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

6.  Differentiation and long-term survival of C2C12 myoblast grafts in heart.

Authors:  G Y Koh; M G Klug; M H Soonpaa; L J Field
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

Authors:  D Barba; J Hardin; M Sadelain; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 8.  Gene therapy for diseases of the nervous system.

Authors:  J Fick; M A Israel
Journal:  West J Med       Date:  1994-09

9.  An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells.

Authors:  A I Geller; M J During; Y J Oh; A Freese; K O'Malley
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

10.  Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain.

Authors:  C A Lucidi-Phillipi; F H Gage; C W Shults; K R Jones; L F Reichardt; U J Kang
Journal:  J Comp Neurol       Date:  1995-04-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.